BOPPY-based novel fluorescent dopamine D2 and D3 receptor ligands

被引:9
|
作者
Elek, Milica [1 ]
Dubiel, Mariam [1 ]
Mayer, Laura [2 ]
Zivkovic, Aleksandra [1 ]
Mueller, Thomas J. J. [2 ]
Stark, Holger [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Inst Organ Chem, Univ Str 1, D-40225 Dusseldorf, Germany
关键词
Dopamine; BOPPY; D2R; D3R; Fluorescence; Ligands; HIGHLY FLUORESCENT; HIGH-AFFINITY; BODIPY DYES; D3; SCHIZOPHRENIA; BIOLOGY; BINDING; PROBES; TARGET;
D O I
10.1016/j.bmcl.2022.128573
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dopamine is one of the crucial neurotransmitters in the human brain. Its out-of-range concentration can lead to various neurological diseases with special interest for dopamine D-2 and D-3 receptor subtypes. Although BODIPY is a highly versatile structural moiety for fluorescence labeling, we have looked out for structurally related pyridine-based moieties. We used BOPPY labelling of well-described D2R/D3R pharmacophores to obtain ligands with moderate to low nanomolar binding affinities as well as low to excellent quantum yields for bright fluorescence ligands. To best of our knowledge, this is the first report on the application of BOPPY fluorophores to GPCR ligands. This approach offers a general applicable way for fluorescence labelling via primary aliphatic amine elements.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Fluorescent ligands for dopamine D2/D3 receptors
    Allikalt, Anni
    Purkayastha, Nirupam
    Flad, Khajidmaa
    Schmidt, Maximilian F.
    Tabor, Alina
    Gmeiner, Peter
    Huebner, Harald
    Weikert, Dorothee
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] Fluorescent ligands for dopamine D2/D3 receptors
    Anni Allikalt
    Nirupam Purkayastha
    Khajidmaa Flad
    Maximilian F. Schmidt
    Alina Tabor
    Peter Gmeiner
    Harald Hübner
    Dorothee Weikert
    Scientific Reports, 10
  • [3] Talipexole variations as novel bitopic dopamine D2 and D3 receptor ligands
    Stank, Lars
    Frank, Annika
    Hagenow, Stefanie
    Stark, Holger
    MEDCHEMCOMM, 2019, 10 (11) : 1926 - 1929
  • [4] Aromatic linker variations in novel dopamine D2 and D3 receptor ligands
    Di Biase, Cristian
    Leitzbach, Luisa
    Frank, Annika
    Zivkovic, Aleksandra
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2024, 357 (08)
  • [5] Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands
    Elek, Milica
    Djokovic, Nemanja
    Frank, Annika
    Oljacic, Slavica
    Zivkovic, Aleksandra
    Nikolic, Katarina
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2021, 354 (06)
  • [6] Dopamine D2/D3 receptor availability and venturesomeness
    Bernow, Nina
    Yakushev, Igor
    Landvogt, Christian
    Buchholz, Hans-Georg
    Smolka, Michael N.
    Bartenstein, Peter
    Lieb, Klaus
    Gruender, Gerhard
    Vernaleken, Ingo
    Schreckenberger, Mathias
    Fehr, Christoph
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2011, 193 (02) : 80 - 84
  • [7] On dopamine D2 and D3 receptor pharmacology - Ekman,A
    不详
    NORDIC JOURNAL OF PSYCHIATRY, 1996, 50 (06) : 499 - 500
  • [8] Effects of dopamine D2/3 ligands on cocaine discrimination in dopamine D3 receptor KO and WT mice
    O'Callaghan, MJ
    Xu, M
    Katz, JL
    FASEB JOURNAL, 2005, 19 (04): : A511 - A511
  • [9] Novel Bivalent Ligands for D2/D3 Dopamine Receptors: Significant Cooperative Gain in D2 Affinity and Potency
    Gogoi, Sanjib
    Biswas, Swati
    Modi, Gyan
    Antonio, Tamara
    Reith, Maarten E. A.
    Dutta, Aloke K.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 991 - 996
  • [10] Effects of dopamine D3/D2 receptor agonists on body temperature and locomotion in dopamine D3 or D2 receptor knock-out mice
    Boulay, D
    Depoortere, R
    Perrault, G
    Sanger, DJ
    BRAIN RESEARCH, 1998, 809 (01) : A25 - A25